Dr. Batalini is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5777 E. Mayo Boulevard
Phoenix, AZ 85050- Is this information wrong?
Summary
- Dr. Batalini is a medical oncologist focused on the treatment of breast and gynecological cancers. He completed his training at Harvard and MIT is an Assistant Professor of Oncology and Co-Director of Genetics and Biochemistry at the Mayo Clinic Alix School of Medicine. He is a member of the American Society of Clinical Oncology (ASCO) and American Association for Cancer Research (AACR). Dr. Batalini leads research in the fields of genetics and genomics, with expertise on precision oncology, liquid biopsies, DNA damage and repair, and the development of new treatments for cancer patients. His clinical and research focus includes: (1) Precision medicine: identifying genetic alterations unique to each patient to guide treatment choices or clinical trial participation. (2) Liquid biopsies: studies the incorporation of new technologies to individualize care and bring research findings to patient care. (3) DNA damage and repair: development of genomic biomarkers of homologous recombination repair. (4) Hereditary cancers: expertise on the treatment of patients with strong family history of cancer or carriers of hereditary mutations of cancer risk genes, including BRCA1, BRCA2, and others.
Education & Training
- Broad Institute of MIT and HarvardPostdoctoral fellowship, Genomics and Computational Biology, 2019 - 2025
- Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2018 - 2021
- Boston University Medical CenterResidency, Internal Medicine, 2015 - 2018
- Universidade Estadual de LondrinaClass of 2010, MD
Certifications & Licensure
- MA State Medical License 2015 - 2031
- AZ State Medical License 2021 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 22 citationsPhase 1b Clinical Trial with Alpelisib plus Olaparib for Patients with Advanced Triple-Negative Breast Cancer.Felipe Batalini, Niya Xiong, Nabihah Tayob, Madeline Polak, Julia Eismann
Clinical Cancer Research. 2022-04-14 - 22 citationsPhase 1b Clinical Trial with Alpelisib plus Olaparib for Patients with Advanced Triple-Negative Breast Cancer.Felipe Batalini, Niya Xiong, Nabihah Tayob, Madeline Polak, Julia Eismann
Clinical Cancer Research. 2022-04-14 - 25 citationsHigh-Dose Melphalan and Stem Cell Transplantation in Patients on Dialysis Due to Immunoglobulin Light-Chain Amyloidosis and Monoclonal Immunoglobulin Deposition DiseaseFelipe Batalini, Laura Econimo, Karen Quillen, J. Mark Sloan, Shayna Sarosiek
Biology of Blood and Marrow Transplantation. 2018-01-01
Journal Articles
- Response of Brain Metastases From PIK3CA-Mutant Breast Cancer to AlpelisibFelipe Batalini, Stacy L Moulder, Eric P Winer, Hope S Rugo, Nancy U Lin, Gerburg M Wulf, JCO Precision Oncology, 5/2020
- Challenges in Interpreting TP53 Pathogenic Variants With a Low Minor Allele Frequency in Germline Genetic Testing: A Case Report of a Patient With Mosaic Li-Fraumeni S...Ellie G Peacock, Lindsey M Grenon, Felipe Batalini, Nadine Tung, JCO Precision Oncology, 2/28/2020
- Double-hit monomorphic B-cell lymphoma after liver transplantationZabreen Tahir, Julia Peters, Kathleen Leahy, Felipe Batalini, BMJ Case Reports, 1/1/2020
Professional Memberships
- Member
- Member
Other Languages
- Spanish, Portuguese
External Links
- Google Scholar Profilehttps://scholar.google.com/citations?user=24ju4hcAAAAJ&hl=en&inst=12058184521150304743
- LinkedIn Profilehttps://www.linkedin.com/in/felipebatalini/
- Mayo Clinic Profilehttps://www.mayoclinic.org/biographies/batalini-felipe-m-d/bio-20520053
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: